ePosters 2018

				THURSDAY, SEPTEMBER 13 - Nagelmackers room - Level 2

	\|			11.20 - 12.30 FAMILIAL AND GENETIC ASPECTS OF AORTIC DISEASES
				JURY: Bart Loeys, Dianna Milewicz
	11.20			SMAD2 and SMAD6: two novel genetic players in aortic aneurysm and dissection, Melanie Perik
	11.28			Study of the contribution of copy number variation to the pathogenesis of bicuspid aortic valve associated aortopathy, Ilse Luyckx
	11.36			New insights into fibrillinopathies and pitfalls of variant filtering in the current genomics era, Janine Meienberg
	11.44			Candidate drug testing in murine models of aortic diseases using biomechanical integrity as novel read-out, Nicolo Dubacher
	11.52			MicroRNA-574-5p: a circulating marker of thoracic aortic aneurysm, Adeline Boileau
	12.00			Gene expression in patients with abdominal aortic aneurysm - more than immunological mechanisms involved, Miroslav Prucha
	12.08			Aortic microcalcification is associated with aortopathy in Marfan Syndrome; potential marker for imaging, Vivian de Waard

	\|			16.00 - 18.00 NEW INSIGHTS INTO AORTIC PATHOLOGY AND MANAGEMENT
				JURY: Marc Bailey, Nicos Labropoulos, Lars Maegdefessel
	16.00			Plasminogen activator inhibitor type 1 promote experimental aortic dissection in mice, Yasunori Iida
	16.10			Abdominal aortic aneurysm and IgG4-associated disease, Miroslav Prucha
	16.20			Patients with abdominal aortic aneurysm demonstrate higher levels of non-cholesterol sterol markers of endogenous cholesterol synthesis, Miroslav Prucha
	16.30			Modeling tissue re-modeling during the pathogenesis of abdominal aortic aneurysms, Tina Cohnert
	16.40			Leukotriene B4 plasma levels are associated to AAA prevalence and progression, Mónica M. Torres-Fonseca
	16.50			Investigating the influence of aortic composition on predisposition of aneurysmal disease, Lakmini Liyanage
	17.00			Endovascular treatment of abdominal aortic aneurysm: impact of diabetes on endoleaks and reintervention, Charlotte Praca
	17.10			Wall-layer-specific transcriptome and finite element analysis-derived rupture risk in abdominal aortic aneurysms, Moritz Lindquist Liljeqvist
	17.20			The new adominal aortic stent graft- personal experience with ovation and aorfix stent graft, Stevo Duvnjak
	17.30			Hybrid approach for aortic arch diseases: single center experience, Vitalii Kravchenko
	17.40			Aneurysms – as complication after coarctation of the aorta correction. Frequency, methods and result of treatment, Yurii Tarasenko
	17.50			Outcomes of aortic surgery in a tertiary care hospital: our experience
	18.00			Treatment of blunt aortic isthmus rupture : 16-year single center experience, Pierre-Arnaud Wuidar

				E-POSTERS TO BE PRESENTED IN THE MAIN SESSION

	\|			WEDNESDAY, SEPTEMBER 12
	18.10			Back to basics – Increasing the use of posteroanterior chestradiograph to aid assessment of chest pain for aortic dissection, Sachintha Perera

	\|			THURSDAY, SEPTEMBER 13
	18.48			The images behind intramural haematoma, Andreas Mitsis

	\|			FRIDAY, SEPTEMBER 14
	09.18			Blood glucose, diabetes and abdominal aortic aneurysm among 2 million screened individuals, Dylan Morris
	09.22			Should we screen women for abdominal aortic aneurysm? Ulug Pinar
	09.26			The TAGA study: a new family study for the genetic analysis of aortic abdominal aneurysm, Maria Sabater-Lleal
	11.55			Final findings of the Fenofibrate in the management of AbdoMinal aortic aneurysm (FAME)-2 trial, Joseph Moxon